2012 Q4/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 NovImmune
8.2
2 +10 Siegfried AG
7.8
3 +0 Newron Suisse SA
7.7
4 +5 Piramal Healthcare
7.6
5 -1 GenKyoTex SA
7.6
6 +1 4-Antibody AG
7.6
7 +1 Eisai (company)
7.6
8 +3 Gebro Pharma AG
7.6
9 +1 Kuros Biosurgery AG
7.5
10 +3 LEO Pharmaceutical Products Sarath Ltd.
7.1
11 -6 Wockhardt
6.8
12 +2 Actelion Ltd.
6.8
13 +3 Max Zeller Söhne AG
6.7
14 +9 Eli Lilly Schweiz
6.6
15 +2 Renovo
6.6
16 -1 Helvepharm AG
6.6
17 +1 Sandoz Pharmaceuticals AG
6.5
18 +15 Vifor (International) Ltd.
6.5
19 +21 Galenica Ltd.
6.4
20 -1 Intercytex
6.4
21 +21 Acino Holding AG
6.4
22 +2 Sanofi-Aventis (Schweiz) AG
6.3
23 +3 Astellas Pharma AG
6.2
24 -3 Virbac Schweiz AG
6.1
25 +47 Spirig Pharma AG
6.0
26 +18 STADA Arzneimittel
6.0
27 -21 Cilag AG
6.0
28 +4 BioPartners GmbH
6.0
29 -1 Arpida AG
5.9
30 -1 Evolva SA
5.9
31 +4 Nycomed Pharma AG
5.9
32 +9 Sanofi-Pasteur MSD AG
5.9
33 +0 IBSA
5.9
34 -9 Aptalis
5.8
35 -1 Neurotune
5.8
36 -9 Nectar Lifesciences
5.8
37 -1 Dr. Wild & Co. AG
5.8
38 -1 Kyowa Hakko
5.8
39 +0 Octapharma AG
5.7
40 +6 Debiopharm S.A.
5.7
41 +71 BioVersys GmbH
5.7
42 -22 Astellas Pharma
5.6
43 +4 Addex Pharmaceuticals
5.6
44 +1 Teva Pharma AG
5.6
45 +4 Galapagos NV
5.6
46 +64 Servier Laboratories
5.6
47 +1 Auris Medical AG
5.5
48 +8 Allergan UK
5.5
49 -47 Medinova AG
5.5
50 +7 Actavis
5.5


Changes in rank are compared to 2012 Q3/Global Life Sciences. Since then, 6 sites entered the survey and 55 sites could not be included in the rankings (4 fewer since last time). Build your own. Report statistics.